ArticleThe oncologist2020

Statin Intolerance, Anti-HMGCR Antibodies, and Immune Checkpoint Inhibitor-Associated Myositis: A "Two-Hit" Autoimmune Toxicity or Clinical Predisposition?

Mitchell S von Itzstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.